» Authors » Cagla Eren Cimenci

Cagla Eren Cimenci

Explore the profile of Cagla Eren Cimenci including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 12
Citations 117
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Razavipour M, Gonzalez M, Singh N, Cimenci C, Chu N, Alarcon E, et al.
J Therm Spray Technol . 2023 Jul; 31(1-2):130-144. PMID: 37520908
Graphical Abstract:
2.
Munoz M, Cimenci C, Goel K, Comtois-Bona M, Hossain M, McTiernan C, et al.
ACS Nano . 2022 Feb; 16(3):3522-3537. PMID: 35157804
We report the development, as well as the and testing, of a sprayable nanotherapeutic that uses surface engineered custom-designed multiarmed peptide grafted nanogold for on-the-spot coating of an infarcted myocardial...
3.
Munoz M, El-Khoury A, Cimenci C, Gonzalez-Gomez M, Hunter R, Lomboni D, et al.
ACS Appl Mater Interfaces . 2021 Jun; 13(27):32251-32262. PMID: 34181389
Poly(vinyl chloride) (PVC) is the most used biomedical polymer worldwide. PVC is a stable and chemically inert polymer. However, microorganisms can colonize PVC producing biomedical device-associated infections. While surface modifications...
4.
Munoz M, Comtois-Bona M, Cortes D, Cimenci C, Du Q, Thompson C, et al.
Sci Rep . 2021 Jan; 11(1):1822. PMID: 33469049
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) responsible for the COVID-19 global pandemic has infected over 25 million people worldwide and resulted in the death of millions. The COVID-19...
5.
Lazurko C, Khatoon Z, Goel K, Sedlakova V, Cimenci C, Ahumada M, et al.
ACS Biomater Sci Eng . 2021 Jan; 6(2):1124-1134. PMID: 33464871
A novel strategy is needed for treating nonhealing wounds, which is able to simultaneously eradicate pathogenic bacteria and promote tissue regeneration. This would improve patient outcome and reduce the number...
6.
Pupkaite J, Sedlakova V, Cimenci C, Bak M, McLaughlin S, Ruel M, et al.
ACS Biomater Sci Eng . 2021 Jan; 6(7):4256-4265. PMID: 33463355
Injectable hydrogels are a promising method to enhance repair in the heart after myocardial infarction (MI). However, few studies have compared different strategies for the application of biomaterial treatments. In...
7.
Jacques E, Hosoyama K, Biniam B, Cimenci C, Sedlakova V, Steeves A, et al.
ACS Biomater Sci Eng . 2021 Jan; 6(8):4614-4622. PMID: 33455166
As cell therapies emerged, it was quickly realized that pro-regenerative cells directly injected into injured tissue struggled within the inflammatory microenvironment. By using microencapsulation, i.e., encapsulating cells within polymeric biomaterials,...
8.
Cimenci C, Kurtulus G, Caliskan O, Guler M, Tekinay A
Bioconjug Chem . 2019 Aug; 30(9):2417-2426. PMID: 31415164
Cadherins are vital for cell-to-cell interactions during tissue growth, migration, and differentiation processes. Both biophysical and biochemical inputs are generated upon cell-to-cell adhesions, which determine the fate of the mesenchymal...
9.
Arslan E, Sardan Ekiz M, Cimenci C, Can N, Gemci M, Ozkan H, et al.
Acta Biomater . 2018 Apr; 73:263-274. PMID: 29656073
Statement Of Significance: Osteoarthritis is a debilitating joint disease affecting millions of people worldwide. It occurs especially in knees due to aging, sport injuries or obesity. Although hyaluronic acid-based viscoelastic...
10.
Blackburn N, Vulesevic B, McNeill B, Cimenci C, Ahmadi A, Gonzalez-Gomez M, et al.
Basic Res Cardiol . 2017 Sep; 112(5):57. PMID: 28864889
Advanced glycation end-products (AGEs) have been associated with poorer outcomes after myocardial infarction (MI), and linked with heart failure. Methylglyoxal (MG) is considered the most important AGE precursor, but its...